The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8530490, 167 ID: ALA3664499
Chembl Id: CHEMBL3664499
PubChem CID: 58218248
Max Phase: Preclinical
Molecular Formula: C21H27N3O6S
Molecular Weight: 449.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=c1ccn(COCCCC2(NS(=O)(=O)c3cccc(OCC4CC4)c3)CC2)c(=O)[nH]1
Standard InChI: InChI=1S/C21H27N3O6S/c25-19-7-11-24(20(26)22-19)15-29-12-2-8-21(9-10-21)23-31(27,28)18-4-1-3-17(13-18)30-14-16-5-6-16/h1,3-4,7,11,13,16,23H,2,5-6,8-10,12,14-15H2,(H,22,25,26)
Standard InChI Key: WWJTVFHWOYQYFA-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.53Molecular Weight (Monoisotopic): 449.1621AlogP: 1.59#Rotatable Bonds: 12Polar Surface Area: 119.49Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.52CX Basic pKa: ┄CX LogP: 1.65CX LogD: 1.65Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.48Np Likeness Score: -0.92
References 1. (2013) Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity, 2. (2014) Anti-tumor effect potentiator,